Melanoma Clinical Trial

Observational Study of Iris Tumors

Summary

This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria for tumor group:

Eyes with diagnosis of melanotic or amelanotic iris tumors

Inclusion Criteria for healthy control group:

Eyes without iris defects or lesions

Exclusion Criteria (both groups):

Inability to give informed consent
Inability to maintain stable fixation for OCT imaging
Inability to commit to required study visits
Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
Mature cataracts if found to limit visual potential to worse than 20/40

Study is for people with:

Melanoma

Estimated Enrollment:

100

Study ID:

NCT03809585

Recruitment Status:

Recruiting

Sponsor:

Oregon Health and Science University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Oregon Health & Science University
Portland Oregon, 97239, United States More Info
Denzil Romfh, OD
Contact
503-494-4351
[email protected]
Humberto Martinez, COT
Contact
503-494-7712
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

100

Study ID:

NCT03809585

Recruitment Status:

Recruiting

Sponsor:


Oregon Health and Science University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.